Sam Brusco, Associate Editor11.10.23
ResMed announced that president and chief operating officer (COO) Rob Douglas plans to retire on January 1, 2024.
Douglas will transition to a new role as special advisor to the CEO and stay in a consulting role through December 31, 2024. Further, current president of sleep and respiratory care Lucile Blaise will immediately transition to the role of senior VP of strategy and business development.
“I would like to thank Rob immensely for his more than two decades of dedication to ResMed, our company, our culture, our team, and our mission,” ResMed CEO Mick Farrell told the press. “I wish Rob all the best in his retirement from ResMed, as well as the next phase of his life journey. I would also like to thank Lucile for stepping up in leadership roles for a decade-and-a-half for ResMed, and I know she will continue to contribute strongly to the exciting work of further developing and enhancing our respiratory care strategy. Lastly, I’d like to thank Urvashi for leading our technology organization over the past two years, she’s built a strong team that is well-positioned to support our new product organization. I’m more excited than ever about ResMed’s future, the changes we’ve made position us well to accelerate profitable growth for the benefit of all stakeholders.”
ResMed also revealed a new operating model, introducing dedicated leadership in product, revenue, and marketing to the executive team.
“ResMed is the undisputed leader in digital health for respiratory medicine and residential care, and we aspire to make ourselves even more Product-led, Customer-centric, and Brand-enhanced. Today, we are making bold changes to ensure these capabilities are directly represented in our executive leadership team,” said Farrell. “We will measure the success of our new operating model through increased product velocity, increased vigilance on long-term profitable revenue delivery, and increased brand engagement with stakeholders.”
The leaders named to new roles include:
Douglas will transition to a new role as special advisor to the CEO and stay in a consulting role through December 31, 2024. Further, current president of sleep and respiratory care Lucile Blaise will immediately transition to the role of senior VP of strategy and business development.
“I would like to thank Rob immensely for his more than two decades of dedication to ResMed, our company, our culture, our team, and our mission,” ResMed CEO Mick Farrell told the press. “I wish Rob all the best in his retirement from ResMed, as well as the next phase of his life journey. I would also like to thank Lucile for stepping up in leadership roles for a decade-and-a-half for ResMed, and I know she will continue to contribute strongly to the exciting work of further developing and enhancing our respiratory care strategy. Lastly, I’d like to thank Urvashi for leading our technology organization over the past two years, she’s built a strong team that is well-positioned to support our new product organization. I’m more excited than ever about ResMed’s future, the changes we’ve made position us well to accelerate profitable growth for the benefit of all stakeholders.”
ResMed also revealed a new operating model, introducing dedicated leadership in product, revenue, and marketing to the executive team.
“ResMed is the undisputed leader in digital health for respiratory medicine and residential care, and we aspire to make ourselves even more Product-led, Customer-centric, and Brand-enhanced. Today, we are making bold changes to ensure these capabilities are directly represented in our executive leadership team,” said Farrell. “We will measure the success of our new operating model through increased product velocity, increased vigilance on long-term profitable revenue delivery, and increased brand engagement with stakeholders.”
The leaders named to new roles include:
- Chief product officer: Justin Leong (previously president, Asia and Latin America)
- Chief marketing officer: Katrin Pucknat (previously president, Germany)
- Chief revenue officer: Mike Fliss (previously vice president, North America sales)